Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 1× · first seen 09-sep-2026 · last seen 09-sep-2026

mPGES-2 Inhibitors (SZ0232)

Current understanding

To be populated as evidence accumulates.

Evidence log

  • 2026-07-01 — Podocyte mPGES-2 Determines Renal Aging and Contributes to Senile Osteoporosis.: Mouse study: podocyte-specific mPGES-2 deletion and pharmacological inhibition with SZ0232 reduced PGE/EP1-driven podocyte senescence, attenuated renal aging, and improved bone microarchitecture in aged mice, nominating a kidney–bone axis mechanism for senile osteoporosis. [animal-model] (novelty: 3)

Open questions

Related

Contributing findings

pubmed preclinical animal-model
Podocyte mPGES-2 Determines Renal Aging and Contributes to Senile Osteoporosis.
01-jul-2026 novelty 3 per-area 3 strengthens

build build 880 · 2bcef25 · 2026-11-18